Exacerbation-free COPD: A goal too far?

Stephen I. Rennard, Tim Higenbottam

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The seventh Lund COPD workshop focused on exacerbations. As chronic obstructive pulmonary disease (COPD) progresses, exacerbations, events characterized by acute worsening of symptoms, increase in frequency and severity. Patients fear their occurrence, as they compromise function and quality of life, may require admission to the hospital, and can be fatal. There are therapies that improve outcome of exacerbations, such as antibiotics and corticosteroids. More importantly, some treatments, such as regular inhaled bronchodilator therapy (particularly with long-acting agents), inhaled corticosteroids, and vaccination against influenza virus, can partially prevent attacks. However, exacerbations remain a challenge, as no therapy effectively banishes them. The current symposium, "Exacerbation-free COPD, a goal too far?", was designed to address this problem. The challenge addressed by the participants was whether more effective treatments could be developed that could further eliminate COPD exacerbations.

Original languageEnglish (US)
Pages (from-to)583-585
Number of pages3
JournalProceedings of the American Thoracic Society
Volume4
Issue number8
DOIs
StatePublished - Dec 1 2007

Fingerprint

Chronic Obstructive Pulmonary Disease
Disease Progression
Adrenal Cortex Hormones
Therapeutics
Bronchodilator Agents
Orthomyxoviridae
Fear
Vaccination
Quality of Life
Anti-Bacterial Agents
Education

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Exacerbation-free COPD : A goal too far? / Rennard, Stephen I.; Higenbottam, Tim.

In: Proceedings of the American Thoracic Society, Vol. 4, No. 8, 01.12.2007, p. 583-585.

Research output: Contribution to journalArticle

Rennard, Stephen I. ; Higenbottam, Tim. / Exacerbation-free COPD : A goal too far?. In: Proceedings of the American Thoracic Society. 2007 ; Vol. 4, No. 8. pp. 583-585.
@article{8c70baecdf7b4068bfab089bbeed5ad8,
title = "Exacerbation-free COPD: A goal too far?",
abstract = "The seventh Lund COPD workshop focused on exacerbations. As chronic obstructive pulmonary disease (COPD) progresses, exacerbations, events characterized by acute worsening of symptoms, increase in frequency and severity. Patients fear their occurrence, as they compromise function and quality of life, may require admission to the hospital, and can be fatal. There are therapies that improve outcome of exacerbations, such as antibiotics and corticosteroids. More importantly, some treatments, such as regular inhaled bronchodilator therapy (particularly with long-acting agents), inhaled corticosteroids, and vaccination against influenza virus, can partially prevent attacks. However, exacerbations remain a challenge, as no therapy effectively banishes them. The current symposium, {"}Exacerbation-free COPD, a goal too far?{"}, was designed to address this problem. The challenge addressed by the participants was whether more effective treatments could be developed that could further eliminate COPD exacerbations.",
author = "Rennard, {Stephen I.} and Tim Higenbottam",
year = "2007",
month = "12",
day = "1",
doi = "10.1513/pats.200707-098TH",
language = "English (US)",
volume = "4",
pages = "583--585",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "8",

}

TY - JOUR

T1 - Exacerbation-free COPD

T2 - A goal too far?

AU - Rennard, Stephen I.

AU - Higenbottam, Tim

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The seventh Lund COPD workshop focused on exacerbations. As chronic obstructive pulmonary disease (COPD) progresses, exacerbations, events characterized by acute worsening of symptoms, increase in frequency and severity. Patients fear their occurrence, as they compromise function and quality of life, may require admission to the hospital, and can be fatal. There are therapies that improve outcome of exacerbations, such as antibiotics and corticosteroids. More importantly, some treatments, such as regular inhaled bronchodilator therapy (particularly with long-acting agents), inhaled corticosteroids, and vaccination against influenza virus, can partially prevent attacks. However, exacerbations remain a challenge, as no therapy effectively banishes them. The current symposium, "Exacerbation-free COPD, a goal too far?", was designed to address this problem. The challenge addressed by the participants was whether more effective treatments could be developed that could further eliminate COPD exacerbations.

AB - The seventh Lund COPD workshop focused on exacerbations. As chronic obstructive pulmonary disease (COPD) progresses, exacerbations, events characterized by acute worsening of symptoms, increase in frequency and severity. Patients fear their occurrence, as they compromise function and quality of life, may require admission to the hospital, and can be fatal. There are therapies that improve outcome of exacerbations, such as antibiotics and corticosteroids. More importantly, some treatments, such as regular inhaled bronchodilator therapy (particularly with long-acting agents), inhaled corticosteroids, and vaccination against influenza virus, can partially prevent attacks. However, exacerbations remain a challenge, as no therapy effectively banishes them. The current symposium, "Exacerbation-free COPD, a goal too far?", was designed to address this problem. The challenge addressed by the participants was whether more effective treatments could be developed that could further eliminate COPD exacerbations.

UR - http://www.scopus.com/inward/record.url?scp=37349083829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349083829&partnerID=8YFLogxK

U2 - 10.1513/pats.200707-098TH

DO - 10.1513/pats.200707-098TH

M3 - Article

C2 - 18073386

AN - SCOPUS:37349083829

VL - 4

SP - 583

EP - 585

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 8

ER -